The Mexican population has a high frequency of de novo DMD mutations, highlighting the importance of direct carrier detection methods like quantitative PCR over linkage analysis.
Answers are grounded in this paper and cite their sources.
Supports direct carrier detection over linkage in Mexican DMD/BMD families; leaves open generalizability pending confirmatory studies.
Duchenne muscular dystrophy (DMD) is the most common lethal hereditary neuromuscular disease. As there is no effective treatment, accurate carrier detection is essential for genetic counseling and prevention. Although linkage analysis has been widely used for this purpose, being an indirect analysis it has several limitations. Using linkage analysis for carrier detection, we found serious limitations, mainly because 82.9% of all proposita were isolated cases. We used quantitative polymerase chain reaction for direct carrier detection in families with exon deletions and found a higher than expected frequency of de novo deletions (62.2%). Furthermore, only 20.7% of the mothers of isolated deletion DMD/Becker muscular dystrophy (BMD) patients were found to be carriers. This result suggests that the Mexican population has a high frequency of de novo DMD mutations.
No takes yet. Share an insight, caveat, or question.
Alcántara et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: